Navigation Links
Loyola receives $1.5 million grant to study vitamin D for diabetes and depression
Date:6/19/2013

MAYWOOD, Il. A Loyola University Chicago Niehoff School of Nursing researcher has received a four-year, $1.49 million grant to study whether Vitamin D can improve mood in women with diabetes who are depressed.

The study also will examine whether vitamin D supplementation can reduce blood pressure and affect how well women manage their diabetes. The grant is from the National Institute of Nursing Research at the National Institutes of Health.

Principal investigator Sue M. Penckofer, PhD, RN and colleagues hypothesize that women receiving vitamin D will report fewer depressive symptoms. In turn, their improved mood will help them to better manage their disease by, for example, eating properly, taking their medications and getting enough exercise. A small pilot study at Loyola found that vitamin D conferred such benefits.

"Vitamin D supplementation is potentially an easy and cost-effective therapy, with minimal side effects," Penckofer said.

Penckofer and her Loyola co-investigators plan to enroll 180 women who have Type 2 diabetes, show symptoms of depression and have low levels of vitamin D in their blood. Women will be randomly assigned to receive either a weekly vitamin D supplementation (50,000 International Units) or a matching weekly placebo for six months.

Earlier studies have found that depressed people have elevated levels of inflammatory biomarkers, notably cytokines and C-reactive protein (CRP). The study will explore whether vitamin D supplementation decreases inflammatory biomarkers, thus providing evidence for a plausible mechanism for how the vitamin works as an antidepressant.

The study is titled "Can the Sunshine Vitamin Improve Mood and Self-Management in Women with Diabetes?

About 1 in 10 people in the United States has diabetes, and the incidence is projected to increase to 1 in 4 persons by 2050. Women with type 2 diabetes have worse outcomes than men. The reason may be due to depression, which affects more than 25 percent of women with diabetes. Depression impairs a patient's ability to manage her disease.

Many Americans do not get enough vitamin D, and people with diabetes are at especially high risk for vitamin D insufficiency or deficiency. Reasons include limited intake of foods high in vitamin D, obesity, lack of sun exposure and genetic variations.

Penckofer is internationally known for her research on vitamin D, diabetes and depression. In October, she will be inducted as a Fellow in the American Academy of Nursing for her scientific contributions in improving the health and quality of life of women with chronic disease. And she recently was appointed as the first nurse researcher to the Chicago Diabetes Center for Translational Research.


'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Related medicine news :

1. Workers do not quit due to mandatory flu shot, says Loyola study
2. Loyola Students’ Anti-Bullying Campaign Wins University’s Eighth National Bateman Competition Title
3. NBC Nightly News Veteran Tom Brokaw to Speak at Loyola University New Orleans’ Spring 2013 Commencement
4. Jennifer Aggas to Receive $4,500 Scholarship to Loyola University New Orleans’ Top-Ranked Online Master of Science in Nursing
5. Loyola University New Orleans is Highest Ranked Jesuit Online Graduate Nursing Program
6. Suzanna Stone to Receive $4,500 Scholarship to Loyola University New Orleans’ Top-Ranked Online MS in Nursing
7. Suzanna Stone to Receive $4,500 scholarship to Loyola University New Orleans’ Top-Ranked Online MS in Nursing
8. Sarah Foster to Receive $4,500 Scholarship to Loyola University New Orleans’ Top-Ranked Online Master of Science in Nursing
9. Loyola University New Orleans Presents a History of Nursing in its New Infographic: Nursing Evolution
10. AHA awards Loyola more than $60,000 for cardiac research
11. Loyolas orthopaedic physical therapy residency program is credentialed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... insurance assistance and financial planning services to communities in the greater Birmingham area, ... to provide resources to underprivileged young people in the region. , The Chris ...
(Date:7/21/2017)... ... ... Bernard R. Bach, Jr., MD, orthopaedic surgeon at Rush University Medical Center ... Medicine (AOSSM) , received the 2017 Robert E. Leach Sports Medicine Leadership award on ... award is given annually to honor those who have made a significant contribution to ...
(Date:7/21/2017)... ... , ... “Kids aren't born knowing how to regulate their emotions any more ... of St. Louis-based positive education company Generation Mindful. To help with that daunting task, ... , The kit uses colorful, engaging and educational illustrations and games to teach ...
(Date:7/21/2017)... CANADA (PRWEB) , ... July 21, 2017 , ... ... insight into why concussion rates are on the rise, say researchers presenting their ... today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns of ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... law firm headquartered in Houston, is pleased to announce their expansion to the ... affordable housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
(Date:7/5/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ... clinical grade cell and tissue hypothermic storage ... that it has reached an agreement with WAVI Holding ... modify its existing credit facility effective June 30, 2017. ... to exchange its existing $4.25 million credit facility, including ...
(Date:6/27/2017)... 27, 2017  Therapix Biosciences Ltd. (Nasdaq: ... in the development of cannabinoid-based drugs, today announced that ... Bell in New York, NY ... initial public offering (IPO) of American Depository Shares (ADSs) ... Dr. Elran Haber, Ph.D., Chief Executive Officer ...
Breaking Medicine Technology: